https://pubmed.ncbi.nlm.nih.gov/33632218/#:~:text=ResultsBy2050thePPI,inChinaandIndiarespectively. Archives

The epidemiologic impact and cost-effectiveness of new tuberculosis vaccines on multidrug resistant tuberculosis in India and China

We investigated the epidemiologic impact, cost-effectiveness, and budget impact of hypothetical novel prophylactic prevention of disease TB vaccines on RR/MDR-TB in China and India.